[The aim of this review is the biology of the EGFR and its use as a target for a new class of anticancer agents for colorectal cancer.Results available so far demonstrated a manageable and acceptable toxicity profile and a promising level of activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE